Eaton Vance Management Veracyte, Inc. Transaction History

Eaton Vance Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.94 - $42.51 $78,984 - $153,036	-3,600 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $961 - $1,430	-27 Reduced 0.74%	3,600 $0
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $68,548 - $117,826	2,081 Added 134.61%	3,627 $145,000
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $68,750 - $125,813	1,546 New	1,546 $83,000

307

81.7M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.93B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.